TRI's Spotlight on Mental Health Keynote Speaker

Join us for TRI's Spotlight on Mental Health keynote speaker

By Translational Research Institute (TRI)

Date and time

Mon, 5 Sep 2022 1:00 PM - 2:30 PM AEST

Location

Translational Research Institute

37 Kent Street Woolloongabba, QLD 4102 Australia

About this event

Join us as we launch TRI's Mental Health Week 2022. Our 'Spotlight on Mental Health' keynote speaker will be taking place on Monday 5th September, with lunch in the Atrium at 1:00pm, then hear from our keynote speaker Donna Thistlethwaite from Mentally Wellthy in the Auditorium at 1:30pm.

Donna Thistlethwaite has risen above dark days to become a fierce mental health advocate. One Sunday afternoon in August 2012, Donna experienced a mental health crisis which led her to jump off the Story Bridge in a suicide attempt. She miraculously survived and has made it her mission to share her story of survival, recovery and hope. In her keynote presentation, Donna will share her insights and journey of recovery to empower others on wellbeing and building resilience.

Date: Monday 5th September 2022

Time: 1:30pm - 2:30pm (lunch at 1:00pm)

Location: TRI Auditorium and Atrium + Zoom

Donna Thistlethwaite

Donna Thistlethwaite is a mental health and resilience trainer and professional speaker with a background in human resources. She has worked with staff and leaders at all levels across the private and public sector. Donna is passionate about supporting people, doing this both within her technical expertise and through speaking about mental health, drawing on her lived experience. She is focused on helping organisations and individuals to THRIVE.

Organised by

Translational Research Institute (TRI)

The Translational Research Institute (TRI) is a leading Australian medical research, development and translation facility. It is home to a broad range of cutting-edge research into cancer, chronic diseases, mental health conditions, immunology, genetics and more. TRI’s priority is partnering scientific development with clinicians and the MedTech sector to ensure new discoveries progress quickly and improve patient outcomes and commercial return. To this end, TRI is at the interface of science, medicine and industry. Our vision is Exceptional Science, Healthier Lives.

Situated on the Princess Alexandra Hospital precinct, TRI is a joint venture between Queensland Health, The University of Queensland, the Queensland University of Technology and Mater Research.

TRI houses more than 1000 leading researchers, support staff and students and has a community of bio-tech and med-tech start-up companies as well as industry bodies located on its campus. The Institute has two clinical trial facilities, one based at the PA Hospital and the other at the Centre for Children’s Health Research next to the Children’s Hospital.

GET INVOLVED

Sales Ended